Genes (Jan 2022)

Genotype-Phenotype Comparison in POGZ-Related Neurodevelopmental Disorders by Using Clinical Scoring

  • Dóra Nagy,
  • Sarah Verheyen,
  • Kristen M. Wigby,
  • Artem Borovikov,
  • Artem Sharkov,
  • Valerie Slegesky,
  • Austin Larson,
  • Christina Fagerberg,
  • Charlotte Brasch-Andersen,
  • Maria Kibæk,
  • Ingrid Bader,
  • Rebecca Hernan,
  • Frances A. High,
  • Wendy K. Chung,
  • Jolanda H. Schieving,
  • Jana Behunova,
  • Mateja Smogavec,
  • Franco Laccone,
  • Martina Witsch-Baumgartner,
  • Joachim Zobel,
  • Hans-Christoph Duba,
  • Denisa Weis

DOI
https://doi.org/10.3390/genes13010154
Journal volume & issue
Vol. 13, no. 1
p. 154

Abstract

Read online

POGZ-related disorders (also known as White-Sutton syndrome) encompass a wide range of neurocognitive abnormalities and other accompanying anomalies. Disease severity varies widely among POGZ patients and studies investigating genotype-phenotype association are scarce. Therefore, our aim was to collect data on previously unreported POGZ patients and perform a large-scale phenotype-genotype comparison from published data. Overall, 117 POGZ patients’ genotype and phenotype data were included in the analysis, including 12 novel patients. A severity scoring system was developed for the comparison. Mild and severe phenotypes were compared with the types and location of the variants and the predicted presence or absence of nonsense-mediated RNA decay (NMD). Missense variants were more often associated with mild phenotypes (p = 0.0421) and truncating variants predicted to escape NMD presented with more severe phenotypes (p p = 0.0004). Our study suggests that gain-of-function or dominant negative effect through escaping NMD and the location of the variants in the prolin-rich domain of the protein may play an important role in the severity of manifestations of POGZ–associated neurodevelopmental disorders.

Keywords